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Abstract
Background: Available methods for the joint modelling of longitudinal and time-to-event outcomes have typically
only allowed for a single longitudinal outcome and a solitary event time. In practice, clinical studies are likely to
record multiple longitudinal outcomes. Incorporating all sources of data will improve the predictive capability of
any model and lead to more informative inferences for the purpose of medical decision-making.
Methods: We reviewed current methodologies of joint modelling for time-to-event data and multivariate
longitudinal data including the distributional and modelling assumptions, the association structures, estimation
approaches, software tools for implementation and clinical applications of the methodologies.
Results: We found that a large number of different models have recently been proposed. Most considered jointly
modelling linear mixed models with proportional hazard models, with correlation between multiple longitudinal
outcomes accounted for through multivariate normally distributed random effects. So-called current value and
random effects parameterisations are commonly used to link the models. Despite developments, software is still
lacking, which has translated into limited uptake by medical researchers.
Conclusion: Although, in an era of personalized medicine, the value of multivariate joint modelling has been
established, researchers are currently limited in their ability to fit these models routinely. We make a series of
recommendations for future research needs.
Keywords: Joint models, Multivariate data, Longitudinal data, Time-to-event data, Software
Abbreviations: GFR, Glomerular filtration rate; GLMM, Generalised linear mixed model; JLCM, Joint latent class
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Background
In many clinical studies, subjects are followed-up repeat-
edly and response data collected, for example a bio-
marker. The time to an event is also usually of interest,
which might be explicit, e.g. death, or implicit, e.g. dropout.
The longitudinal data may be censored by this time-to-
event outcome. Modelling the longitudinal and event-time
outcomes separately, for example using linear mixed
models [1] or Cox regression models [2], can therefore be
inefficient, and can lead to biased effect size estimates if the
two outcome processes are correlated [3].
Research into joint modelling of longitudinal and time-
to-event data has received considerable attention during
the past two decades [3–7]. The motivation behind this
active field of research has stemmed from three broad
scientific objectives:
(1)Improving inference for a repeated measurement
outcome subject to an informative dropout
mechanism that is not of direct interest [8].
(2)Improving inference for a time-to-event outcome,
whilst taking account of an intermittently and
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error-prone measured endogenous time-dependent
variable [5].
(3)Studying the relationship between the two correlated
processes [6].
Depending on the objective, previous approaches to
joint modelling have included fitting time-dependent
Cox models [2], and two-stage models [9, 10]. In each
case, joint modelling can lead to improvements in the ef-
ficiency of statistical inferences and reduces bias [11],
which can yield substantial benefits when designing tri-
als. Joint models can also be used to improve prediction
[12], or to determine whether a longitudinal process is a
surrogate for a time-to-event process [10]. The literature
is extensive, with comprehensive reviews given by Hogan
and Laird [13], Tsiatis and Davidian [14], and Gould
et al. [15].
Previous research has mostly concentrated on the joint
modelling of a single longitudinal outcome and a single
time-to-event outcome; herein referred to as univariate
joint modelling. Commensurate with this methodological
research has been an increase in wide-ranging clinical
application [16–21] and accessibility to analysis tools
using mainstream statistical software packages [22–28]. In
practice, however, the data collected will often be more
complex, featuring multiple longitudinal outcomes and
possibly multiple, recurrent or competing event times. As
an example, Rizopoulos and Ghosh [29] described data on
407 patients with chronic kidney disease who underwent a
renal transplantation. Each patient had 3 separate bio-
marker measurements repeatedly recorded: glomerular fil-
tration rate (GFR), blood haematocrit level, and proteinuria.
Each of these can be considered as markers of renal func-
tion, with the clinical interest being the time to graft failure.
Harnessing all available information in a single model is ad-
vantageous and should lead to improved model predictions.
This therefore makes multivariate joint modelling an at-
tractive tool in an era of personalized medicine, as physi-
cians can gain a better understanding of the underlying
disease dynamics and ultimately choose the most optimal
treatment for a patient at a particular follow-up time
point. Notwithstanding the increased flexibility and bet-
ter predictive capabilities, the extension of the classical
univariate joint modelling framework to a multivariate
setting introduces a number of technical and computa-
tional challenges.
A number of factors, many still faced by the univar-
iate joint modelling framework, precludes integration
of this more sophisticated modelling framework into
routine clinical research practice [15]. The aim of this
paper is to provide an overview of recent methodo-
logical developments and applications of joint models
for time-to-event data and multivariate longitudinal
data (MVJMs).
Methods
A MVJM is comprised of two submodels: (1) a multi-
variate longitudinal data model, and (2) a time-to-event
data model.
Let Yik(tijk) denote the j-th observed value of the k-th
longitudinal outcome for subject i, measured at time tijk,
for i = 1, …, N; k = 1, …, K, and j = 1, …, nik. There are a
plethora of modelling approaches for multivariate longi-
tudinal data [30]. A generalized linear mixed model
(GLMM) is a common approach, where measurements
for different outcomes can be recorded at different times
between patients and outcomes, and is given by:
hk E Y ik tijk
    ¼ μik tijk ; ð1Þ
where hk(⋅) denotes a known one-to-one link function
for the k-th outcome, and μik(⋅) is the linear predictor:
μik tijk
  ¼ X 1ð Þik tijk β 1ð Þk þ Zik tijk bik ; ð2Þ
where Xik
(1)(tijk) and Zik(tijk) are row-vectors of (possibly
time-varying) covariates for subject i associated with
fixed and random effects respectively, which can vary by
outcome; βk
(1) is a vector of fixed effects parameters for
the k-th outcome; and bik is a vector of subject-specific
random effects for the k-th outcome. We denote the
stacked vector of subject-specific random effects for all
K outcomes by bi = (bi1
T, bi2
T, …, biK
T )T.
Cox’s proportional hazards (PH) semiparametric
model [2] has been a common choice for the time-to-
event submodel when modelling continuous event times.
For a single failure-time per subject, the hazard function
for subject i at time t is given by
λi tð Þ ¼ λ0 tð Þ exp X 2ð Þi tð Þβ 2ð Þ þWi tð Þ
n o
; ð3Þ
where Xi
(2)(t) is a (possibly time-varying) row-vector of
external covariates; λ0(t) denotes the baseline hazard
function; β(2) is a vector of fixed effects parameters; and
Wi(t) is a latent process that captures the association
structure between the measurement and event processes.
When the PH assumption is not met, alternative model-
ling frameworks can be exploited, such as accelerated
failure time models, which can be written directly in
terms of the survival function, Si(t), as
Si tð Þ ¼ S0 exp X 2ð Þi tð Þβ 2ð Þ þWi tð Þ
n o
t
 	
;
where S0(⋅) is the baseline survival function that depends
on the parametric family used for modelling, and all
other parameters are defined as per the PH model (3).
Discrete event times can also be jointly modelled with
longitudinal data, particularly for selection models,
which is applicable to situations of interval-censored
continuous event times and predefined measurement
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schedules. Models here might include logistic or probit
regression models [31]. We can generally represent the
discrete distribution function as a function of the latent
association term, namely F(Xi
(2)(tj)β
(2) +Wi(tj)).
In principle, each submodel can be fitted separately.
However, this can result in biased estimates and a loss of
efficiency when the processes are correlated. When bik
and Wi(t) are jointly modelled, it leads to the so-called
shared random effects joint model. A graphical represen-
tation of this model is shown in Fig. 1. Joint models
might also fall under the umbrellas of pattern-mixture
models or selection models depending on the factorization
of the joint distribution of event time and longitudinal
data [31, 32]. Furthermore, modelling approaches might
also fall under the umbrellas of joint latent class models
[33], semiparametric [34], and fully parametric models
[35]. We note also that the topic of missing values in lon-
gitudinal data analyses has its own literature [36]. In the
MVJM literature, focus has mainly been towards shared
random effects models. We review the different submo-
dels, including distributional assumptions and correlation
structures, latent association structures, estimation tech-
niques, software implementations, and give clinical exam-
ples of application.
Results
Longitudinal data submodel
The choice of model for the longitudinal outcome data
will depend on the type of data measured (continuous,
ordinal, discrete). Although in the development and
application of MVJMs they are often restricted to the
simple case of continuous outcomes only [17, 19–21,
37–53], it is conceivable that multiple outcomes might
be a mixture of different outcome types. For example, in
Rizopoulos and Ghosh [29], GFR and haematocrit were
both continuous measures, whereas proteinuria was
recorded as a binary outcome. More recent modelling
approaches developed have incorporated combinations
of different outcome types [4, 18, 29, 54–65]. Other models
have considered multivariate binary [66], ordinal [67, 68],
and continuous [0,1]-bounded data [44, 45, 47, 53].
Thiébaut et al. [41] and Guedj et al. [52] both proposed a
model for multiple continuous outcomes, but also allowed
for left-censoring, which is a pertinent issue with biomarker
measurements as they can fall below the minimum detec-
tion level.
Model
For continuous longitudinal outcomes, the Laird and
Ware [1] linear mixed model (LMM) with independent
and identically normally distributed within-subject
measurement errors is ubiquitous. However, this distri-
butional assumption can be sensitive to outlier observa-
tions and heavy-tailed data, which has prompted robust
modelling considerations in the univariate framework
[69]. Despite this, it has translated into only limited
model innovation in the MVJM framework, with Tang
and Tang [49] considering using the multivariate skew-
Fig. 1 Graphical representation of a joint model of a time-to-event submodel and K-multivariate longitudinal outcomes submodel. Square boxes
denote observed data; circles denote unobserved (including random) terms. The black-dashed box indicates that covariates can be shared
between both submodels. The red-dashed box indicates that the process Wi(t) and the random effects, bi, are correlated, which gives rise to the joint
model. Ti is the failure time, which may or may not be observed, in which case a censoring time is observed. All other notation is defined as above
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normal distribution. The robustness of model estimates
to misspecification of errors, error structures, and mag-
nitude of errors, has been examined through several
simulation studies [40, 43, 49, 50]. Dantan et al. [44] and
Proust-Lima et al. [45, 57] considered a model for [0, 1]-
bounded continuous data using the Beta transformation
link function, as it is parsimonious and offers very flex-
ible shapes. This, however, might require a preliminary
rescaling of the markers. Liu and Li [47] and Hatfield et
al. [53] also considered data on the [0, 1] interval, but in-
stead used zero-one inflated and ‘zero-augmented’ beta
regression models, respectively. Guedj et al. [52] pro-
posed a completely different approach by modelling
multivariate continuous biomarkers using a mechanistic
model based on a system of nonlinear ordinary differen-
tial equations.
For binary and count data, the standard model is the
GLMM. This model has been regularly used in the
MVJM framework [4, 18, 29, 54–56, 58, 60–63, 66, 70].
Moreover, this can be extended to multivariate data of
different outcome types (e.g. a combination of continu-
ous and binary measures) with correlation induced by
modelling the random effects together. Huang et al. [66]
considered a logistic regression model for binary out-
come data, with a logistic regression model for the un-
observed latent variable and a linear pairwise odds-ratio
model for the association between marginal probabilities.
Models for ordinal data have been considered, including
the proportional odds model [18, 54, 55, 64, 67], cumu-
lative probit model [57], partial proportional odds model
[68], and the continuation ratio mixed model [56, 59].
Random effects distributions
In the univariate joint model framework, it has been re-
ported that inferences are generally robust to misspecifi-
cation of random effects [71, 72]. However, in the
MVJM framework the dimension of these random ef-
fects might be greater, potentially amplifying the impact
of misspecification on parameter estimates and standard
errors. In general, the ubiquitous normality assumption
might be too restrictive to capture individual-level vari-
ation [49]. Nonetheless, multivariate normal distribu-
tions are the standard modelling choice for random
effects in the longitudinal submodel. Several simulation
studies have generated data under misspecified random
effects [43, 49, 60, 68]. Pantazis and Touloumi [43] ex-
plored misspecification by fitting their proposed model
[40] to data simulated under a range of heavy tailed,
skewed, and mixture distributions. They concluded that
fixed effect parameter estimates were quite robust to
misspecification with the exception of those in the time-
to-event submodel, but standard errors may be underes-
timated for heavily skewed distributions. These findings
were in agreement with those found by Li et al. [68].
Xu et al. [58] explored the sensitivity of the parameter
estimates to a multivariate t-distribution for the random
effects. Tang and Tang [60] investigated the effect of
misspecification on their semiparametric model by simu-
lating data with random effects drawn independently
from uniform and relocated Gamma distributions. Song
et al. [38] simulated random effects from a bimodal nor-
mal mixture distribution to confirm the robustness of
the semiparametric estimator; whereas Rizopoulos and
Ghosh [29] simulated random effects from a three-
component normal mixture model to confirm the ro-
bustness of the Dirichlet process prior formulation.
To avoid misspecification, it can be advantageous to
semiparametrically model the random effects. In the
Bayesian paradigm, extended from the univariate frame-
work [73], a Dirichlet process has been used to specify
the random effects prior distribution [29, 49, 60]. The
subject-specific random effects were assumed to be inde-
pendently and identically distributed according to some
unknown density function, which is modelled by the
Dirichlet prior [74]. Song et al. [38] treated the random
effects as nuisance parameters, for which a set of esti-
mating equations were deduced based on a derived suffi-
cient statistic. Li et al. [68] also proposed a method
whereby the distributions of the assumed zero-mean
random effects could be left completely unspecified and
estimated entirely non-parametrically by exploiting the
vertex-exchange method.
Discrete random effects confer an advantage in model
estimation by replacing (possibly high-dimensional) nu-
merical integration by summations that are more man-
ageable. Bartolucci and Farcomeni [61] introduced two
discrete random effects: one that follows a single first-
order latent Markov chain distribution, and a second
time-constant latent variable to account for unobserved
heterogeneity. Huang et al. [66] also used independent
discrete random effects to account for association be-
tween events and longitudinal outcomes.
Correlation structure
Multidimensional random effects are usually treated as
correlated and modelled with a multivariate normal dis-
tribution with unstructured covariance matrix; however,
independence and other structures have been consid-
ered. Ibrahim et al. [19] considered an unstructured cor-
relation between the random effects, but also explored
using a more parsimonious (and computationally faster)
diagonal covariance matrix. Proust-Lima et al. [45, 57]
included subject-class-level specific random effects in
the latent variable model, and subject-outcome-level
specific random intercepts in the longitudinal submodel.
The subject-outcome random-intercepts were distrib-
uted normally with outcome-specific variance. The
subject-class random effects, however, were distributed
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multivariate normally with latent-class specific mean
and an unstructured covariance matrix multiplied by a
(latent) class-specific proportionality parameter. Musoro
et al. [17] considered two types of random effects in the
multivariate longitudinal submodel: the standard
subject-specific random effects modelled by a multivari-
ate normal distribution, and basis-outcome-specific ran-
dom effects for the thin-plate spline used to model time,
modelled according to independent normal distributions
with basis-outcome specific variances. Li et al. [68] and
Choi et al. [65] factorised the random effects as bik = Γkbi,
which reduces the dimension of random effects. For
large K, Hatfield et al. [53] also discussed alternative
simpler correlation structures for the random effects.
Although correlation between the multiple longitu-
dinal outcomes can be modelled through the subject-
specific random effects, it can alternatively be mod-
elled through correlated error terms [19, 20, 38, 39,
42, 49, 60, 70]. Using the notation from (2) assuming
a multivariate LMM with normal errors and multiple
outcomes recorded according to a single measure-
ment schedule, we have
Y ik tij
  ¼ X 1ð Þik tij βk 1ð Þ þ Zik tij bik þ εijk :
Let also εij ⋅ = (εij1
T , …, εijK
T )T denote the vector of errors
for the k-th outcome. Xu and Zeger [58] considered the
approach of correlated subject-specific random effects;
namely
εijk∼Nð0; σ2kÞ; and bi∼Nvð0;ΨÞ;
where σk
2 is an outcome-specific variance term, and Ψ is
a (v × v)-covariance matrix capturing the correlation be-
tween markers and repeated measures. Chi and Ibrahim
[42] on the other hand considered the approach of cor-
related error terms; namely:
εij: ∼NK 0; Σð Þ; and bik∼Nvk 0; Ψkð Þ;
where Σ is a covariance matrix that captures the associ-
ation between longitudinal outcomes measured at the
same time, and Ψk is a covariance matrix that captures
the association between the random effects for the k-th
outcome (with the vector bik of length vk). Chi and Ibra-
him noted that their model allows for dependence be-
tween repeated measures and correlation between
longitudinal outcomes to be considered separately,
whereas in the Xu and Zeger model the different correl-
ation types are conflated. Notwithstanding the inferential
benefit, the latter model requires additional covariance
parameters be estimated, which increases the computa-
tional challenge. Interestingly, Baghfalaki et al. [64] re-
placed the random effects term completely independent
of outcome k, which whilst allowing for correlation be-
tween outcomes, in general will not be biologically
plausible as subject-specific deviations will be on differ-
ent scales for disparate longitudinal outcomes.
An alternative approach to model correlation between
multiple longitudinal outcomes is to introduce a com-
mon latent variable between the models. Ibrahim et al.
[19] considered the model
Y ik tij
  ¼ β0k þ β1kμi tij  þ εijk ;
where μi(tij) is the true unobserved latent variable at
time tij. For example, if K different immunological mea-
surements were recorded from a blood sample at time
tij, then we might let μi(tij) denote the ‘true antibody
level’, which we cannot observe, but which we can infer
from the multivariate outcome. The model is completed
by specifying the latent variable model, e.g. as in (2), and
a distribution for the error terms. For example, Ibrahim
et al. considered εij. ∼NK(0, Σ), and Luo [55], εijk ∼
N(0, σk
2). Guedj et al. [52] intrinsically accounted for cor-
relation between multiple biomarkers through the sys-
tem of dependent ODE equations that models the
biological system.
Within-subject autocorrelation structures, e.g. Henderson
et al. [6], are not routinely considered; although Wang et al.
[67] introduced a Gaussian process model for the under-
lying latent variable with a power function of time model-
ling the correlation. Proust-Lima et al. [57] considered the
inclusion of a flexible zero-mean Gaussian autocorrelated
process that admits Brownian motion and autoregressive
processes as special cases. Ibrahim et al. [19], Pantazis et al.
[40], and Hatfield et al. [53] noted their models could be ex-
tended to autocorrelation, but at the expense of added
computational burden.
In some cases, where multivariate longitudinal data
has been collected, the correlation has been ignored in
order to allow simpler univariate joint models to be ap-
plied. For example, Battes et al. [21] used an ad hoc ap-
proach of either summing or multiplying the three
repeated continuous measures (standardized according
to clinical upper reference limits of the biomarker as-
says), and then applying standard univariate joint
models.
Time-to-event data submodel
Commonly, event times are measured continuously. If
the subject does not experience the event of interest
during the study observation period, then they are right-
censored at the last known follow-up time. In some
cases, where there is delayed entry to the study, it is
necessary to account for left truncation [45, 57, 62]. In
the MVJM framework, discrete event times have also
been considered, [46, 50, 51, 61, 66]. Bartolucci and
Farcomeni [61] noted that their estimation method could
be extended to include continuous right-censored event
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times at a cost of loss of information and efficiency. Dan-
tan et al. [44] also considered discrete time, but the model
applied was relevant to continuous time also. These
models do not permit premature non-informative censor-
ing before the end of the study. However, Albert and Shih
[46] suggested that if subjects are censored before the end
of the study, then a separate precursory model could be
used to impute the event times prior to application of the
joint model methodology.
In practice, clinicians might not only be interested in
multivariate longitudinal outcomes, but also multivariate
time-to-event data. For example, Chi and Ibrahim [42]
were interested in assessing whether different quality of
life measures were prognostic and predictive of breast
cancer progression in a drug randomised controlled
trial (RCT). In addition to the multivariate longitudinal
outcomes, the study monitored patients concerning two
event times: overall survival and disease-free survival.
Tang et al. [60], Tang and Tang [49], and Zhu et al. [70]
each proposed multiple events joint models, motivated
by the same dataset as analysed by Chi and Ibrahim
[42]. Musoro et al. [17] considered a case of multiple
recurrent events, where each patient could become
repeatedly infected with one of 9 different infections.
Huang et al. [66] analysed data from a complex preven-
tion trial, with an interest on whether different inter-
ventions were associated with times to initiation of
alcohol use and tobacco use. Competing risks data have
recently been considered in the context MVJMs also
[56, 57, 59, 68].
Model
The Cox PH model is an attractive choice as no distribu-
tional assumptions are required on the time-to-event
data. In some settings, the unspecified baseline hazards
function has been replaced by either a piecewise con-
stant step-function for some preselected knots [18, 19,
29, 39, 47, 49, 54, 57, 59, 60, 70], or modelled using
spline functions, including B-splines [4, 56], M- (and I-)
splines [45, 57], and restricted cubic splines [62]. The
position of knots is usually decided in advance, for ex-
ample by taking quantiles (e.g. [59]), though advice is
generally lacking. As an added degree of flexibility,
Proust-Lima et al. [45, 57] consider class-specific (and
cause-specific where applicable) baseline hazards that
can be either stratified by class m = 1,…,M, i.e. λ0m(t),
or proportional by class, i.e. exp(βm)λ0(t), for some
parameters βm.
Parametric models considered in the MVJM framework
include the Weibull [20, 45, 52, 53, 55, 57, 62, 64, 65], ex-
ponential [20, 52, 62, 65], log-normal [40, 41, 43, 55, 64],
log-logistic [55], and Gompertz [57, 62]. Hu et al. [48]
used a Weibull model for imputing composite event
times, but used a conditional multinomial logistic
regression model to then impute the cause type. The soft-
ware package by Crowther [62] also allows for the
Royston-Parmar model [75] to be fitted, which is a flexible
parametric model that models the log-cumulative hazard
using restricted cubic splines. For models involving
multivariate event time data, standard models were
applied; notably, for competing risks data the cause-
specific hazards model was applied [76]. Chi and
Ibrahim [42] developed a novel multivariate survival
model that accommodates both zero and non-zero
cure fractions, and which has a PH structure condi-
tionally and marginally under certain settings. Hu et
al. [48] developed an imputation approach that first
imputed a composite event time, and then imputed a
cause type using a conditional multinomial regression
model.
The pattern-mixture model approach by Fieuws et
al. [63] used the Kaplan-Meier estimator to model the
failure time, which they described as prior probabil-
ities, which were used in an elegant Bayes rule to cal-
culate the conditional probability of failure. Models
considering discrete time data have utilised a number
of discrete probability models, including the probit
model [46], logistic model [50], discrete time log-
linear hazard models [66], truncated geometric distri-
bution [50, 51, 61], and discrete proportional hazards
model [50].
Frailty
Random effects are also included in some time-to-event
submodels, to account for correlation between different
or repeated events, where they are referred to as frailty
effects when multiplicative on the hazard. Chi and Ibra-
him [42] proposed a power stable law distribution to ac-
count for correlation between multiple event times. Lin
et al. [37] and Choi et al. [65] respectively included
gamma and log-normally distributed frailty terms to
allow for subject-level variability.
Association structures
Fundamental to the joint modelling framework is the
association structure between the longitudinal submo-
del and the time-to-event submodel. Rationale for
selecting this association structure has received rela-
tively little attention. McCrink et al. [32] state that
the choice of association structure should reflect the
study focus, namely whether it is with respect to the
time-to-event or longitudinal submodel (or both). For
a discussion of different association structures for uni-
variate joint models, see Rizopoulos [4]. We consider below
different representations for Wi(t) applied in the MVJM
framework (Table 1). MVJMs that fall outside of the
ubiquitous shared random effects framework cannot be
reduced to simply specifying Wi(t), and so we describe
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these models separately. In some cases, one might want to
use different association structures for different longitu-
dinal outcomes. This is a greatly overlooked modelling
issue, which to the best of our knowledge, only Andrino-
poulou et al. [56] and Crowther [62] have considered.
Time-dependent associations
The standard joint model assumes that risk of an event
at time t depends on the true value of the longitudinal
profile for the same time point (Table 1, A1)—the so-
called current value parameterization. The strength of the
association is fully interpretable: exp(αk) is the hazard ratio
for a unit increase in μik(t), at time t. An alternative
current value parameterization is to replace the linear pre-
dictor term by the expected value of the longitudinal tra-
jectory function at time t, hk
− 1(μik(t)) (Table 1, A2), which
is of importance for correctly modelling the functional
form. The current value parameterization can be extended
to incorporate additional structure, including interaction
terms with the covariates (Table 1, A3), which might yield
more realistic inferences as it is conceivable that different
associations exist for different patient subgroups. In some
cases one might posit that the risk depends not on the
current value, but on a previous value, giving rise to the
time-lagged values parameterization (Table 1, A4). Current
value parameterizations have been used in model frame-
works not compatible with (3). Chi and Ibrahim [42]
adopted a novel bivariate time-to-event model whereby
covariates—including a current values parameterizatio-
n—are entered by a method corresponding to a canonical
link in a Poisson generalized linear model. Song et al. [38]
developed a model such that Wi(t) = α
Tψ(t, bi), for some
vector function ψ (Table 1, A5). The estimation method-
ology assumed that ψ(t, bi) could be factorised into ψ(t, bi)
=ψ(t)bi, which admits the current value parameterization
as a special case, and leads to a number of extensions in-
cluding interactions with time. In cases where ψ(t, bi) does
not factorise, meaning that it is nonlinear in t, the authors
propose using a linear approximation method.
Derivative terms allow one to incorporate not only the
current value of the true longitudinal process, but also
the rate of change, which intuitively might be associated
with risk of the event. For example, two patients might
have the same observed longitudinal outcome at time t,
Table 1 Some association structures for joint models of time-to-event and multivariate longitudinal data
Parameterization Latent association Studiesi
A1: Current value (linear predictor) Wi tð Þ ¼
XK
k¼1αkμik tð Þ [17, 19, 21, 29, 37, 39, 42, 48, 49, 52, 56, 58, 60, 62, 67, 70]
A2: Current value (expected value)a Wi tð Þ ¼
XK
k¼1αkh
1
k ðμikðtÞÞ [62]
A3: Interactionb Wi tð Þ ¼
XK
k¼1 αkμik tð Þ þ
Xp
l¼1x
2ð Þ
il μik tð Þγkl
n o
[37]
A4: Lagged timec Wi tð Þ ¼
XK
k¼1αkμikðt  cÞ [46]
A5: General vector functiond Wi tð Þ ¼ aTψ t; bið Þ [38]
A6: Time-dependent slopese Wi tð Þ ¼
XK
k¼1 μik tð Þ þ
XV
v¼1αvk
dv
dtv
μik tð Þ

 
[29, 56]
A7: Cumulative effects
Wi tð Þ ¼
XK
k¼1αk
Z t
0
μik sð Þds [56]
A8: Random effectsf
Wi tð Þ ¼
XK
k¼1α
T
k bik [18, 29, 53–55, 59, 62, 64, 65, 68]
A9: Generalised random
effects + fixed effectsg
Wi tð Þ ¼
XK
k¼1α
T
k r bik þ β̃k
1ð Þ 	
[29, 50, 51, 59, 62]
A10: Correlated random effectsh WiðtÞ ¼ θiwithðbTi ; ; ; θiÞ
T
∼Fa [29]
Notation: μik(t) denotes the linear predictor term of the longitudinal submodel for subject i and outcome k; αk denotes the association parameter for the
k-th outcome
ahk(⋅) is the link function for the k-th outcome
bxil
(2) denotes the l-th baseline covariates for subject i (l = 1,…, p) with corresponding coefficient parameters γkl for each outcome k. In practice, some γkl
coefficients will be set to zero
cc is a lag time (with c = 0 returning the current value parameterization). In Albert and Shih [46], time was modelled discretely and a selection model adopted,
such that Wi(tj) = ∑k = 1
K αkμik(tj − 1)
dα is a vector of association parameters and ψ(t, bi) is a vector of time and random effects. It is assumed that ψ(t, bi) can be decomposed as ψ(t, bi) = ψ(t)bi. This
general parameterization admits the current value parameterization as a special case, and leads to a number of extensions including interactions with time. In
cases where ψ(t, bi) does not factorise, the authors propose using an approximation method
eαvk denote additional association parameters for the ν-th derivative (with respect to time) for the k-th longitudinal outcome mean trajectory function
fαk denotes a vector of association parameters of same dimension as the number of random effects for each outcome. In practice, some elements of αk might be
forced to zero, e.g. if only random intercepts were used to link the model
gas per the random effects parameterization αk denotes a vector of association parameters of same dimension as the number of random effects for each
outcome. β̃
1ð Þ
k denotes the subset of coefficient parameters from βk
(1) that correspond to the random effect terms, and r(⋅) denotes a vector function. If r(⋅) is the
identify function, then the standard random + fixed effects parameterization is returned
hFα denotes a multivariate density function with parameters α to model correlation
iRizopoulos [4] describes a general MVJM and notes that, in principle, the general association structures that are used in the R JM package [27] are applicable to
the multivariate case. However, the model was only described without fitting or application, therefore we have not included these association structures here
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but one patient’s trajectory might be rising considerably
more quickly than the other patient’s. Wi(t) can there-
fore be augmented to include the current value plus the
first V derivate terms (Table 1, A6), although this model
is typically only used with the first order derivatives (V
= 1), giving rise to the time-dependent slopes
parameterization. The antithesis of the time-dependent
slopes parameterization is the cumulative effects
parameterization (Table 1, A7). Here, a summary of the
entire history of the longitudinal process up to time t is
included in the hazard model, λi(t). This is contrary to
other association structures that relate the hazard func-
tion only to features of the longitudinal model at a fixed
time point.
Random effects parameterization
The above parameterizations often require numerical inte-
gration, which presents a computational challenge. Simpler
time-independent associations can overcome this. The ran-
dom effects parameterization (Table 1, A8), which only in-
cludes the time-independent random effects, is therefore
frequently used in joint models. This parameterization has
been used by a number of authors in various ways. In the
simple case of a random-intercepts and random-slopes
model for (2), the random effects represent the subject-
specific deviation from the average intercept and slope fixed
effect terms. Nevertheless, experts have echoed caution
when attempting to use these models for inference, as com-
plex longitudinal trajectory functions, such as those mod-
elled by polynomials or splines, lead to non-interpretable
association parameters [4, 15]. On the other hand, Jaffa et
al. [50, 51] were specifically interested in the multivariate
LMM slopes, so there was a clear a priori rationale for
this association structure. Moreover, they noted that their
model does not preclude inclusion of the random-
intercepts, but demonstrated that specifying the marginal
time-to-event (dropout) model is only required. Random ef-
fects parameterizations are sometimes used to refer to
models where the hazard is associated with random plus
fixed effect terms (Table 1, A9). For example, rather than
model risk as dependent on bik, one assumes it is dependent
on bik þ β
∼
k
1ð Þ
, where β
∼
k
1ð Þ
is a subset of βk
(1) that correspond
to the random effects terms in bik. This model can be gener-
alised to include functions of random coefficients.
Correlated random effects and frailty
An alternative approach to specifying an association
structure is not to directly include random effects com-
ponents of the longitudinal submodel in the time-to-
event submodel, but rather to include separate random
effects in each, and specify a joint distribution for the la-
tent terms (Table 1, A10). In the simplest case, one can
set Wi(t) = θi, and then jointly model (bi
T, θi)
T. Rizopou-
los and Ghosh [29] considered such a structure, assum-
ing that the joint distribution was unknown, and used a
Dirichlet prior to fit the model.
Correlated random effects and error
Pantazis et al. [40], Thiébaut et al. [41], and Pantazis and
Touloumi [43] assumed a log-normal distributional for
the event times, i.e. log(Ti) = Xi
(2)β(2) + ei, where the error
terms ei are assumed to follow a normal distribution
with mean 0 and variance σT
2 . The multivariate longitu-
dinal data submodel and log-normal event time submo-
del were associated by assuming that (bi
T, ei)
T are jointly
distributed. When the random effects are multivariate
normally distributed, this distribution is also multivariate
normal. The covariance terms cov(bik, ei) can then sub-
sequently be used to quantify and test the strength of
association.
Joint latent class models
An alternative approach to joint modelling is the use of
joint latent class models (JLCMs). The assumption
underlying JLCMs is that the population of subjects is
heterogeneous, but consists of a number of homoge-
neous latent subgroups for which the subjects share the
same mean longitudinal trajectories and hazard risk. A
review of JLCMs is given by Proust-Lima et al. [33]. A
class-specific latent process mixed model, which we refer to
as the latent variable model to remain consistent with
other similarly structured models, conditional on subject i
being in class m, is then specified following a standard
LMM: μiðtijkÞ
ci¼m ¼ Xð1Þi ðtijkÞβð1Þ þ ZðtijkÞbim . The fixed
effects coefficients can also be made class-specific [57]. The
observed multivariate longitudinal data are modelled using
GLMMs or other suitable measurement models conditional
on this latent variable: hk(Yijk) = μi(tijk) + αik + εijk, for some
suitable link functions hk(⋅). If β
(1) is forced to be class-
specific, then one might introduce additional covariates
with a global fixed effects coefficient vector into the meas-
urement model [57]. There are two sets of random effects
in this model: the subject-class effects in the latent process
model, and the subject-outcome effects in the longitu-
dinal data submodel. The time-to-event submodel
might be modelled as a proportional hazards model,
λi(t | ci =m) = λ0m(t)exp(Xi
(2)βm
(2)). The class member-
ship probabilities are modelled using multinomial re-
gression models. As JLCMs do not require precise
modelling of the association structure between the differ-
ent submodels, with the association captured entirely by
the latent classes, this means that they are not necessarily
well suited for evaluating assumptions regarding the asso-
ciation between the two submodels; however, they are par-
ticularly useful for predictive modelling.
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Other
Other MVJM approaches that fall outside of the ubiqui-
tous shared random effects model framework or the
emerging joint latent class model framework, lead to al-
ternative association structures. Fieuws et al. [63] used a
pattern-mixture model approach. Here, the dependency
derived from the longitudinal submodels being fitted con-
ditional on the failure times. Hu et al. [48] proposed a
model that incorporates some function of the history of
the longitudinal data, which reduces to the current value
parameterization as a special case. Bartolucci and Farcomeni
[61] proposed a discrete time event-history model with a
mixed latent Markov model. A flexible association structure
was obtained though the introduction of two discrete latent
variables: a time-varying latent variable distributed according
to a finite first-order latent Markov chain, and a time-
constant latent variable.
Estimation techniques
Historically, complete likelihood analysis was precluded
by the inherently complex likelihood functions, necessi-
tating so-called two-stage models [9, 10]. However, these
models have been shown to lead to biased results [77]. A
number of estimation approaches have been considered
for MVJMs, building on the methodological develop-
ments in the univariate joint model literature [5, 78].
Frequentist model estimation
The expectation-maximisation (EM) algorithm [79] was
the original estimation approach for joint-likelihood uni-
variate joint models [5, 6], and therefore continues to be
employed in a number of MVJM approaches [37, 40, 43,
61, 68]. At the M-step, maximization was routinely im-
plemented using both closed-form estimators and the
Newton-Raphson algorithm. Some noteworthy exten-
sions included the one-step-late algorithm [37] and re-
stricted iterative generalized least squares [40, 43]. The E-
step was typically implemented using numerical integra-
tion, including Gaussian quadrature (e.g. [adaptive] Gauss-
Hermite), although Monte Carlo integration [37], exten-
sions of the forward-and-backwards recursion method [61],
and exploitations of multivariate normal and truncated nor-
mal distributions [40, 43], were also implemented. Full
maximum likelihood estimation can also be implemented
directly by Newtonian-like approaches. These include the
Marquardt algorithm [41, 44, 45, 57], Newton-Raphson
algorithm [62], and robust variance-scoring algorithm [52].
Huang et al. [66] used automatic differentiation—a numer-
ical technique for simultaneously evaluating a function and
its derivatives—with a Newton-Raphson algorithm, which
was purportedly faster than the EM algorithm.
For estimation methods based on likelihood maximization,
evaluating an approximated inverse observation matrix
at the maximum likelihood estimate is a standard
approach [37, 41, 45, 52, 61, 62, 66] of calculating
standard errors. Semiparametric time-to-event models
have been noted to result in underestimation of param-
eter standard errors [80] in the univariate joint model
framework, and can be unfeasible as the information
matrix increases with sample size. One approach to
overcome this is the bootstrap method, which has been
adopted in MVJM approaches [46, 68]. Pantazis et al.
[40] and Pantazis and Touloumi [43] estimated stand-
ard errors by refitting the model with multiply imputed
data for censored survival times, which is quicker than
conventional EM algorithm approaches.
Bayesian model estimation
The Bayesian approach has a number of advantages and
has been previously exploited in the univariate joint mod-
elling framework [78]. One such advantage is the ease of
incorporating hierarchical data, as used by Luo and Wang
[18] as part of a multicentre RCT joint model. Another ad-
vantage is the availability of Markov chain Monte Carlo
(MCMC) sampling algorithms, which allow estimation
from posterior probability density functions that are not
analytically tractable, and which require complex multi-
dimensional integration over the random effects. The
Gibbs sampling algorithm has been the standard choice
[17–19, 29, 39, 42, 47, 49, 53–56, 59, 60, 64, 65, 67, 70],
applied in conjunction with the adaptive rejection algo-
rithm, slice sampling algorithm, block sampling, and
Metropolis-Hastings algorithm. The surge in Gibbs sam-
pling can be partly explained by the use of the BUGS
computer language [81], in particular WinBUGS and
OpenBUGS, which reduces the need for complex analyt-
ical derivation. Deriving the likelihood function, however,
is still challenging, and depending on the time-to-event
model and latent association, numerical integration might
be required. For example, Ibrahim et al. [19] used an
approximation similar to that used by Tsiatis et al. [10]
that is convenient so long as the response does not change
over time too rapidly compared to the scheduled
longitudinal data measurements. Brown et al. [39] on the
other hand used a simple trapezoidal rule. Gaussian quad-
rature, such as the Gauss-Kronrod rule, has also been used
[29, 56, 59, 60]. Liu and Li [47] compared the performance
of Bayesian approaches to classical frequentist (maximum
likelihood) approaches under different strengths of associ-
ation, demonstrating superiority of the Bayesian methods
with respect to bias, root-mean square error, and coverage.
Another advantage to Bayesian modelling is the ability to
incorporate prior knowledge. Tang and Tang [49] explored
the sensitivity of results to prior distribution selection,
showing that good prior knowledge led to marginally im-
proved estimation. Uncertainty about posterior parameter
estimates is readily calculated from the MCMC output
without need for further complex calculations.
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Other estimation approaches
Song et al. [38] extended the semiparametric conditional
score estimator for the parameters in the hazard rela-
tionship, as proposed by Tsiatis and Davidian [14] in the
univariate framework, which treats the random effects
as nuisance parameters, and a set of estimating equa-
tions are deduced based on a derived sufficient statistic.
Parameter standard errors were subsequently estimated
using a sandwich matrix estimator. Li et al. [68]
employed a non-trivial extension of a method proposed
by Tsonka et al. [82] in order to estimate the model pa-
rameters and zero-mean random effects distribution using
a modified vertex-exchange method algorithm in conjunc-
tion with an expectation-maximization algorithm. Hu et
al. [48] circumvented the classical joint modelling frame-
work by proposing a multiple imputation algorithm using
either a fully conditional specification or MCMC ap-
proach, such that simple and transparent statistical ap-
proaches can be separately applied to the complete data.
Rubin’s rule [83] could then be used to account for the
additional uncertainty in standard errors from imputation.
Albert and Shih [46] proposed a novel two-stage regres-
sion calibration approach. In the first stage, conditional on
each subject’s event time, complete longitudinal data were
simulated for each subject using normal approximations.
Multivariate longitudinal models were then estimated
using the approach of Fieuws and Verbeke [84], which fits
all bivariate models and averages over the duplicate par-
ameter estimates. This method is advantageous as it en-
ables one to consider high-dimensional data, which would
otherwise present numerical challenges or be computa-
tionally infeasible. Following this, an estimator was pro-
posed for the subject-specific random effects, allowing for
estimates of the mean longitudinal trajectories at each
discrete time point for each subject to be obtained. In the
second stage, a regression-calibration approach was then
used to estimate the discrete time-to-event model parame-
ters. The resulting parameter estimates were averaged over
repeated simulations of the model-fitting algorithm. Stand-
ard errors were estimated using the bootstrap method.
Fieuws et al. [63] adopted a pattern-mixture model esti-
mation approach, whereby multivariate longitudinal models
are estimated—separately for those who experience and
those who do not experience the event—again using the
proposed approach of Fieuws and Verbeke [84] described
above. Bayes’ rule was then used to estimate the failure time
distribution conditional on the longitudinal profiles, with a
non-parametric survival distribution acting as the prior
distribution.
Software
The adoption of joint models has been slow [15]. Among
the many reasons for this includes the historically limited
availability of software specific to joint models. Recently
packages for mainstream statistical software, including R
(R Foundation for Statistical Computing, Vienna, Austria)
[24, 27], SAS (SAS Institute, Cary, NC) [26], Stata (Stata-
Corp LP, College Station, TX) [22], and WinBUGS
(MRC Biostatistics Unit, Cambridge, UK) [23], have
allowed researchers to exploit joint modelling. How-
ever, these have been limited to univariate data. Many
articles describing developments or applications of joint
models involving multivariate longitudinal data have re-
ported some details about the software used to fit the
joint models.
R
Brown et al. [39] compiled their flexible B-spline model
for multiple longitudinal biomarkers and time-to-event
outcome (with current value association parameterization)
into an R package, sjmsoft, available from the author’s
website: http://faculty.washington.edu/elizab/software.html
[Accessed: 25 January 2016]. Battes et al. [21] used the R
package JM [27], which fits univariate joint models, by re-
ducing the multivariate longitudinal data to a univariate
outcome through ad hoc techniques. R has also been used
as an interface to execute JAGS [85] and WinBUGS/
OpenBUGS programs [47, 53, 56, 65]. Andrinopoulou et
al. [59] implemented their model using two separate soft-
ware packages, one of which was R, with the code available
from the authors upon request. Tang et al. [60] reported
their Bayesian models were fitted using R and Matlab (The
MathWorks Inc., Natick, MA), with code available from
the authors upon request. Albert and Shih [46] fitted the
bivariate longitudinal models using code presented else-
where [86]. Bartolucci and Farcomeni [61] published R
code as a supplemental file for their event-history exten-
sion Markov model, which depends on compiled Fortran
routines.
BUGS & JAGS
Bayesian MVJMs have been coded in the BUGS lan-
guage and fitted using WinBUGS and OpenBUGS
[18, 29, 53–55, 59, 64, 65]—software that implements
MCMC sampling. JAGS has also been used as alternative
[47, 56], which shares a similar syntax to BUGS models.
The flexibility of the software has permitted countless as-
sociation structures, submodels, and data types. Hatfield
et al. [53] also noted that they extended the WinBUGS
platform to include a ‘zero-augmented beta’ distribution
using code written in Pascal. In the majority of publica-
tions, the model script has been made available in an ap-
pendix [18, 29, 55, 59, 64] or is available on request from
the authors [56, 65]. However, it was generally application
specific; thus requiring adaptation for application with
other datasets.
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Stata
It has recently been announced that the next version re-
lease of the Stata package stjm [22, 87] will allow for
multivariate longitudinal outcomes. The current version
implements maximum likelihood estimation of univariate
joint models with a number of different parametric time-
to-event models. In addition, stjm can jointly model differ-
ent outcome types, different association structures, and
different random effects covariance matrix structures,
alongside extensive optimization control settings, thus
giving the user immense flexibility. A number of post-
estimation options are available, including residual cal-
culation and prediction. Pantazis et al. [40] also report
that a Stata program is available (on request from the
authors) for fitting their bivariate MVJM.
Fortran
Fortran has been used in several MVJM studies [19, 44,
57, 61]. Of particular interest is the HETMIXSURV
(version 2) program available from: http://www.is
ped.u-bordeaux.fr/BIOSTAT [Accessed: 11 April 2006].
This Fortran 90 parallel program implements max-
imum likelihood estimation of the multivariate JLCM
proposed by Proust-Lima et al. [57], in addition to
other related models, which permits different outcome
types and submodels. The R package lcmm [28] has
similar capabilities, but does not currently permit
multivariate longitudinal data in the JLCM framework.
Dantan et al. [44] also fitted a JLCM using Fortran 90,
and note the code is available on request. Ibrahim et al.
[19] also report code is available for fitting their MVJM
and multivariate L-statistic from the authors’ website.
Other
SAS has been implemented in the MVJM literature,
with direct reference to the procedure NLMIXED
[20, 50, 51, 63], but without making the code avail-
able. Song et al. implemented their conditional score
method using C++ [38], and Li et al. [68] fitted their
bivariate ordinal model with competing risks data using
C. In both cases, the code is available from the respective
authors upon request. Matlab was used by Lin et al. [37]
to run the one-step-ahead EM algorithm (code not pro-
vided), and by Tang et al. [60] to implement an MCMC al-
gorithm for a Bayesian MVJM (code available on request
from the authors). Huang et al. [66] developed an S-Plus
(Insightful Corporation, Seattle, WA) library model, AD09,
to implement the automatic differential method that
enables direct maximization of the MVJM likelihood func-
tion. In addition to a Stata program, Pantazis et al. also re-
ported that MLn (Centre for Multilevel Modelling,
University of Bristol, UK) macros are available from the
authors for fitting their bivariate MVJM.
Clinical examples
Most methodological developments in the MVJM frame-
work have been motivated by real-world clinical studies.
Applications have been in the disease areas of HIV/AIDS
[16, 38–41, 43, 52], lung disease [65, 68], cancer [19, 37,
42, 49, 53, 60, 70], cardiovascular disease [21, 56, 59, 67],
neurodegenerative disease [18, 45, 54, 55, 57], renal dis-
ease [17, 29, 48, 50, 51, 63], hepatic disease [46, 61],
mental health [58, 66], and cognitive studies [20, 44].
We illustrate three examples below.
Parkinson’s disease drug trial
Parkinson’s disease is a chronic progressive neurodegen-
erative disorder. Luo and Wang [18] reported data from
a clinical trial of 800 patients randomized in a 2x2 fac-
torial design to receive double-placebo, tocopherol, dep-
renyl, or tocopherol with deprenyl. The latter two
groups formed the treatment group, whilst the former
two defined the placebo group. To investigate the effect
of tocopherol in slowing the progression of Parkinson’s dis-
ease, 3 longitudinal outcomes were recorded that describe
progression: 1 continuous and 2 ordinal measuring differ-
ent facets of the disease. A substantial number of patients
(376/800) failed to complete the measurement schedule (10
measurements over a 24-month follow-up period), due to
deterioration and were treated with levodopa therapy. The
time to initiation of levodopa therapy was the study end-
point. It was shown that patients with shorter follow-up
had worse progression measurements on average; therefore,
a multivariate joint model was required to account for the
informative dropout. For the multivariate longitudinal data,
a multilevel item-response theory model was used, with
centre effects included to account for the cluster-trial de-
sign. A piecewise constant proportional hazards regression
model was used for the time-to-event data, with a shared
(centre-specific and subject-specific) random effects associ-
ation structure (Table 1, A8). Based on multiple model
comparison methods, a random effects parameterization
without centre-level effects was optimal. This model indi-
cated a non-significant effect of tocopherol on disease pro-
gression rate and on the hazard of levodopa therapy
initiation when compared to placebo. However, the associ-
ation parameters were strongly significant, indicating that
patients with worse disease severity and faster disease pro-
gression had an increased hazard of levodopa therapy initi-
ation. This data was also previously analysed by Luo [55]
and He and Luo [54] without consideration of the centre
effects, and in the former case under different parametric
time-to-event models.
Heart valve replacement observational study
Aortic valve replacement is a common cardiac surgery
procedure, often required to treat aortic stenosis.
Andrinopoulou et al. [59] analysed data from a cohort on
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283 patients who survived aortic valve or root replace-
ment with an allograft valve. During the routine clinical
follow-up appointments, two echocardiographic measure-
ments were recorded: valve gradient (continuous) and re-
gurgitation (ordinal). Physiologically, increased gradient or
regurgitation indicates deterioration of valve performance,
which could lead to either death or necessitate reopera-
tion—both events of interest. To investigate the effects of
these parameters on the hazard of adverse events, a
MVJM was proposed for the bivariate longitudinal data
and a competing risks model was assumed for the event
times. A LMM with B-spline functional form was used to
model the non-linear gradient trajectory, and a continu-
ation ratio mixed effects model for the regurgitation data.
A simple LMM for aortic gradient was considered, but re-
sulted in an inferior model fit. A cause-specific event-time
model with piecewise constant baseline hazards was used
to model the competing risks data, with a random effects
(+ fixed effects) association structure (Table 1, A9). The
association between the longitudinal measurements and
events are presented in the form of graphical plots to fa-
cilitate interpretation, as the B-spline parameters are not
straightforwardly interpretable. Andrinopoulou et al. [56]
reanalysed this data with the purpose of calculating dy-
namic predictions. Furthermore, they extended the model
to consider several different association structures, with
subsequent predictions combined using Bayesian model
averaging in order to account for model structure
uncertainty.
Cancer drug trial
Lin et al. [37] reanalysed data from a placebo-controlled
randomized trial to establish whether supplemental
beta-carotene reduces recurrence of the primary
tumours in patients cured from a recent early-stage head
and neck cancer. The primary endpoint was all-cause
mortality, with 63 subjects dying during follow-up. During
the trial, blood samples were taken from 264 patients at
baseline, 3-months, 1-year, and annually thereafter until 5-
years total follow-up was attained. Two continuous bio-
markers—both plasma nutrient concentrations—were of
interest: lycopene and lutein + zeaxanthin. Previous uni-
variate studies had demonstrated that increased biomarker
concentrations were associated with reduced mortality.
Interest here was specifically on whether both biomarkers
were simultaneously associated with mortality. To investi-
gate this, a MVJM was developed with LMMs used to
model the biomarkers, and a Cox PH model to model the
time to death, with association modelled using an inter-
action parameterization (Table 1, A3). Additionally, a
gamma-distributed subject-level frailty term was included
to capture over-dispersion. It was found that the effect of
lutein + zeaxanthin was diminished when both biomarkers
were included, and moreover the sign was opposite to that
of the univariate joint model. By exploring the correlation
between the biomarkers, the authors suggested that the ef-
fect of lutein + zeaxanthin on all-cause mortality appeared
to be mediated only through the association with lycopene.
Lin et al. also demonstrated the necessity of joint model-
ling by fitting (1) a separate event time model with base-
line biomarker concentrations; (2) a time-varying covariate
Cox model (equivalent to a last observation carried-
forward model); and (3) a two-stage joint model, and
juxtaposing each to the fitted MVJM.
Discussion
The case for use of joint models has been made in the
univariate data framework [3]. Similarly in the MVJM
literature, several studies have demonstrated the poten-
tial bias from ignoring the correlation between the out-
comes by comparing joint models to separately fitted
submodels in simulation analyses [18, 40, 42, 47, 54, 55].
With an increased focus on personalised medicine, the
need to implement models that account for multiple
longitudinal outcomes is necessary. Despite this, joint
models have predominantly focused on univariate data.
A consequence of this has been researchers fitting mul-
tiple separate univariate joint models [88], which is ineffi-
cient and can affect inferences [37]. Here we have
presented an overview of MVJM literature. The models
developed in the literature showcase broad classes of lon-
gitudinal and time-to-event data and countless association
structures, with bespoke models often developed to meet
the demands of the clinical data at hand. A small number
of models have even considered simultaneously multivari-
ate longitudinal data and multivariate time-to-event joint
models [17, 42, 48, 49, 56, 59, 60, 66, 68, 70].
One advantage of joint models is that they might im-
prove power and efficiency over separate fitted models
[3]. Nonetheless, few applications of joint models to
clinical trial data have derived from a planned joint
modelling design. For joint models to become embedded
in clinical research, researchers will need guidance on
study design with reference to the different models and
estimation proposals available. However, issues such as stat-
istical power have attracted little attention in the univariate
joint model literature [11, 89]. Furthermore, developments
in the field of joint modelling—particularly MVJMs—have
primarily focused on modelling and estimation. Practi-
tioners will naturally require diagnostic tools to evaluate
model fits and compare models. Articles considering
MVJMs have utilised many different model comparison
methods, goodness-of-fit tests, and diagnostics. In some
cases, these statistical methods have been developed specif-
ically for the multivariate data joint modelling framework.
We illustrate some of the approaches adopted in the litera-
ture in Additional file 1: Table S1.
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The extension from univariate data modelling to
multivariate data modelling is, in principle, straightfor-
ward [4]. The main barrier to applied researchers is the
lack of readily available software that can implement
multivariate joint model estimation approaches; this is
despite an emergence of software relevant to univariate
joint models. The main limitation to statisticians is the in-
herent computational challenge that arises from the in-
creasing dimensionality of the random effects component.
Despite many multivariate models being presented in full
generality, computational power, limits in numerical
estimation, (effective) sample size, and clinical data
availability will, unavoidably in practice, preclude
analyses involving large dimensions. Of the MVJM
methodologies encountered to-date, bivariate data is
the most commonly encountered during application
[19, 20, 37–41, 43, 48, 50, 53, 56, 57, 59, 61, 64, 68],
followed by trivariate data [18, 21, 29, 44–47, 51, 58, 66].
A few articles have considered 4 longitudinal outcomes
[17, 42, 49, 54, 55, 60, 63, 70]. Jaffa et al. [51] explored
converge properties of their MVJM for up to 10 longitu-
dinal outcomes, and reported good performance. It was
also noted that the model should straightforwardly ex-
tended to higher dimensions. Of all the studies involving
multiple event types or competing risks, all were limited
to the bivariate case/two competing risk events, with the
exception of one study [17], which considered 9 separate
recurrent events along with 4 longitudinal biomarkers.
However, in the latter case it was reported that a sin-
gle joint model could not actually be fitted due to
computational limitations, with the authors opting in-
stead to fit multiple pairwise models.
The flexibility of a model to be applied to a given
dataset will depend on the ability to include complex
functional forms and covariate adjustment options
within the submodels. Complex functional forms,
whilst perhaps better capturing non-linear trajector-
ies in the longitudinal submodel that may be
observed in biological data, increase computational
requirements to fit as the dimensions of the random
effects increases. Notwithstanding these issues, some
have developed models which includes complex
smoothing functions within the multivariate frame-
work, including B-splines [39, 59], natural cubic
splines [29, 56, 62], fractional polynomials [62], P-
splines [49], thin-plate splines [17], I-splines [57],
and parametric non-linear functions [43]. Albert and
Shih [46] also noted that their approach could be
extended to nonlinear models with an additional ap-
proximation. The mechanistic model proposed by
Guedj et al. [52] is able to model complex dynamics
of biomarkers by virtue of the complex system of
differential equations specified, which captures knowledge
of actual biological processes.
Conclusions and Recommendations
Gould et al. [15] concluded that it was going to be a
challenge to encourage stakeholders to adopt joint
models. This challenge is further exacerbated when
multivariate longitudinal data are incorporated. How-
ever, as demonstrated in this review there is a solid
methodological foundation to implement these
methods. We have also observed the early phase of
infiltration into the non-statistical biomedical literature
[16, 20, 21], which highlights the potential of the MVJM
framework. For MVJMs to be integrated into the applied
biostatistician’s tool belt, further developments are re-
quired, including:
 Development of statistical software capable of fitting
of MVJMs. Univariate joint models have seen a surge in
software development, which includes wider integration
with multivariate event-time data; however, lack
of software for multivariate longitudinal data will
preclude their use by the vast majority of applied
statisticians.
 Reporting of the maximum dimension limits for
multiple longitudinal outcomes. Whilst many models
are presented in full generality, computational
limitations will preclude large numbers of random
effects, and therefore large numbers of
biomarkers. Currently, little is understood about
this with the exception of short commentaries by
Jaffa et al. [51] and Musoro et al. [17].
 Guidance on the underlying model types,
distributional assumptions, and choice of
association structure. Despite methodological
developments, a coherent and flexible modelling
framework that encapsulates the general
multivariate joint model is lacking, which
precludes penetration into the biomedical arena
due to a lack of understanding.
 Development of model diagnostics and selection
devices compatible with the MVJM framework. A
number of useful ancillary statistical tools have
been recently presented, however clarity and
demonstration of their suitability, as well as integration
into the aforementioned software developments, are
required.
 Study design guidance, including but not limited to:
sample size and power calculations; selection of
appropriate latent association structures; applicability
of models according to different intra- and inter-
patient measurement protocols, and outcome
types; surrogacy; and dynamic prediction.
 Further research into MJVMs with multivariate
time-to-event submodels, including competing risks,
recurrent events, multiples events, and multistate
data.
Hickey et al. BMC Medical Research Methodology  (2016) 16:117 Page 13 of 15
Additional file
Additional file 1: Table S1. Goodness-of-fit tests, model diagnostics,
comparison instruments, and other model assessment tools. (DOCX 162 kb)
Acknowledgements
We thank the Medical Research Council (MRC) for funding GLH’s salary. The
MRC had no influence in the design, collection, analysis, or interpretation of
data; the writing of the manuscript; or the decision to submit the manuscript
for publication.
Funding
This research was funded by Medical Research Council (MRC) grant MR/M013227/1.
Availability of data and materials
Not applicable. No datasets were used in this study.
Authors’ contributions
RKD conceived the intellectual idea. GLH, PP, AJ and RKD designed the study.
GLH wrote the manuscript. All authors reviewed drafts of the manuscript,
offered interpretation and critical comment, and approved the final version.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1Department of Biostatistics, University of Liverpool, Waterhouse Building, 1-5
Brownlow Street, Liverpool L69 3GL, UK. 2Department of Mathematics,
Physics and Electrical Engineering, Northumbria University, Ellison Place,
Newcastle upon Tyne NE1 8ST, UK.
Received: 19 May 2016 Accepted: 12 August 2016
References
1. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics.
1982;38:963–74.
2. Cox DR. Regression models and life-tables. J R Stat Soc Ser B Stat Methodol.
1972;34:187–220.
3. Ibrahim JG, Chu H, Chen LM. Basic concepts and methods for joint models
of longitudinal and survival data. J Clin Oncol. 2010;28:2796–801.
4. Rizopoulos D. Joint Models for Longitudinal and Time-to-Event Data, with
Applications in R. Boca Raton: Chapman & Hall/CRC; 2012.
5. Wulfsohn MS, Tsiatis AA. A joint model for survival and longitudinal data
measured with error. Biometrics. 1997;53:330–9.
6. Henderson R, Diggle PJ, Dobson A. Joint modelling of longitudinal
measurements and event time data. Biostatistics. 2000;1:465–80.
7. Asar O, Ritchie J, Kalra P, Diggle PJ. Joint modelling of repeated
measurement and time-to-event data: an introductory tutorial. Int. J.
Epidemiol. 2015; 1–11.
8. Dupuy J-F, Mesbah M. Joint modeling of event time and nonignorable
missing longitudinal data. Lifetime Data Anal. 2002;8:99–115.
9. Self S, Pawitan Y. Modeling a marker of disease progression and onset of
disease. In: Jewell NP, Dietz K, Farewell VT, editors. AIDS Epidemiol.
Methodol Issues. Boston: Birkhauser; 1992.
10. Tsiatis AA, DeGruttola V, Wulfsohn MS. Modeling the relationship of survival
to longitudinal data measured with error - applications to survival and CD4
counts in patients with AIDS. J Am Stat Assoc. 1995;90:27–37.
11. Hogan JW, Laird NM. Increasing efficiency from censored survival data by
using random effects to model longitudinal covariates. Stat Methods Med
Res. 1998;7:28–48.
12. Rizopoulos D, Hatfield LA, Carlin BP, Takkenberg JJM. Combining dynamic
predictions from joint models for longitudinal and time-to-event data using
Bayesian model averaging. 2013.
13. Hogan JW, Laird NM. Model-based approaches to analysing incomplete
longitudinal and failure time data. Stat Med. 1997;16:259–72.
14. Tsiatis AA, Davidian M. Joint modeling of longitudinal and time-to-event
data: an overview. Stat Sin. 2004;14:809–34.
15. Gould AL, Boye ME, Crowther MJ, Ibrahim JG, Quartey G, Micallef S, Bois FY.
Joint modeling of survival and longitudinal non-survival data: current
methods and issues. Report of the DIA Bayesian joint modeling working
group. Stat Med. 2015;34:2181–95.
16. Touloumi G, Pantazis N, Babiker AG, Walker SA, Katsarou O, Karafoulidou A,
Hatzakis A, Porter K. Differences in HIV RNA levels before the initiation of
antiretroviral therapy among 1864 individuals with known HIV-1
seroconversion dates. AIDS. 2004;18:1697–705.
17. Musoro JZ, Geskus RB, Zwinderman AH. A joint model for repeated events of
different types and multiple longitudinal outcomes with application to a follow-
up study of patients after kidney transplant. Biometrical J. 2014;57:185–200.
18. Luo S, Wang J. Bayesian hierarchical model for multiple repeated measures
and survival data: an application to Parkinson’s disease. Stat Med.
2014;33:4279–91.
19. Ibrahim JG, Chen M-H, Sinha D. Bayesian methods for joint modeling of
longitudinal and survival data with applications to cancer vaccine trials. Stat
Sin. 2004;14:863–83.
20. Ghisletta P. Application of a joint multivariate longitudinal-survival analysis
to examine the terminal decline hypothesis in the Swiss Interdisciplinary
Longitudinal Study on the Oldest Old. J Gerontol B Psychol Sci Soc Sci.
2008;63:185–P192.
21. Battes LC, Caliskan K, Rizopoulos D, Constantinescu AA, Robertus JL, Akkerhuis
M, Manintveld OC, Boersma E, Kardys I. Repeated measurements of NT-pro-B-
type natriuretic peptide, troponin T or C-reactive protein do not predict future
allograft rejection in heart transplant recipients. Transplantation. 2015;99:580–5.
22. Crowther MJ, Abrams KR, Lambert PC. Joint modeling of longitudinal and
survival data. Stata J. 2013;13:165–84.
23. Guo X, Carlin BP. Separate and joint modeling of longitudinal and event
time data using standard computer packages. Am Stat. 2004;58:16–24.
24. Philipson P, Sousa I, Diggle PJ, Williamson PR, Kolamunnage-Dona R,
Henderson R. Package “joineR” [Internet]. R Foundation for Statistical
Computing; 2012. Available from: https://cran.r-project.org/package=joineR.
25. Rizopoulos D. The R Package JMbayes for fitting joint models for longitudinal
and time-to-event data using MCMC. arXiv Prepr. 2014; arXiv:1404.
26. Zhang D, Chen M-H, Ibrahim JG, Boye ME, Shen W. JMFit: a SAS macro for
joint models of longitudinal and survival data. J Stat Softw. 2009;30:1–3.
27. Rizopoulos D. JM: an R package for the joint modelling of longitudinal and
time-to-event data. J Stat Softw. 2010;35:1–33.
28. Proust-Lima C, Philipps V, Liquet B. Estimation of latent class linear mixed
models: the new package lcmm. arXiv Prepr. [Internet] 2015; Available from:
http://arxiv.org/pdf/1503.00890.pdf.
29. Rizopoulos D, Ghosh P. A Bayesian semiparametric multivariate joint model
for multiple longitudinal outcomes and a time-to-event. Stat Med.
2011;30:1366–80.
30. Verbeke G, Fieuws S, Molenberghs G, Davidian M. The analysis of multivariate
longitudinal data: A review. Stat Methods Med Res. 2012;23:42–59.
31. Sousa I. A review on joint modelling of longitudinal measurements and
time-to-event. Revstat Stat J. 2011;9:57–81.
32. McCrink LM, Marshall AH, Cairns KJ. Advances in joint modelling: A review
of recent developments with application to the survival of end stage renal
disease patients. Int Stat Rev. 2013;81:249–69.
33. Proust-Lima C, Sene M, Taylor JMG, Jacqmin-Gadda H. Joint latent class
models for longitudinal and time-to-event data: a review. Stat Methods
Med Res. 2012;23:74–90.
34. Scharfstein DO, Rotnitzky A, Robins JM. Adjusting for nonignorable drop-out
using semiparametric nonresponse models. J Am Stat Assoc. 1999;94:1096–120.
35. Diggle PJ, Sousa I, Chetwynd AG. Joint modelling of repeated
measurements and time-to-event outcomes: the fourth Armitage lecture.
Stat Med. 2008;27:2981–98.
36. Little RJA. Modeling the drop-out mechanism in repeated-measures studies.
J. Am. Stat. Assoc. 1995. 1112–1121.
37. Lin H, McCulloch CE, Mayne ST. Maximum likelihood estimation in the joint
analysis of time-to-event and multiple longitudinal variables. Stat Med.
2002;21:2369–82.
38. Song X, Davidian M, Tsiatis AA. An estimator for the proportional hazards
model with multiple longitudinal covariates measured with error.
Biostatistics. 2002;3:511–28.
Hickey et al. BMC Medical Research Methodology  (2016) 16:117 Page 14 of 15
39. Brown ER, Ibrahim JG, DeGruttola V. A flexible B-spline model for multiple
longitudinal biomarkers and survival. Biometrics. 2005;61:64–73.
40. Pantazis N, Touloumi G, Walker SA, Babiker AG. Bivariate modelling of
longitudinal measurements of two human immunodeficiency type 1
disease progression markers in the presence of informative drop-outs. J R
Stat Soc: Ser C: Appl Stat. 2005;54:405–23.
41. Thiébaut R, Jacqmin-Gadda H, Babiker AG, Commenges D. Joint modelling
of bivariate longitudinal data with informative dropout and left-censoring,
with application to the evolution of CD4+ cell count and HIV RNA viral load
in response to treatment of HIV infection. Stat Med. 2005;24:65–82.
42. Chi YY, Ibrahim JG. Joint models for multivariate longitudinal and
multivariate survival data. Biometrics. 2006;62:432–45.
43. Pantazis N, Touloumi G. Robustness of a parametric model for informatively
censored bivariate longitudinal data under misspecification of its
distributional assumptions: a simulation study. Stat Med. 2007;26:5473–85.
44. Dantan E, Proust-Lima C, Letenneur L, Jacqmin-Gadda H. Pattern mixture
models and latent class models for the analysis of multivariate longitudinal
data with informative dropouts. Int J Biostat. 2008;4:1–26.
45. Proust-Lima C, Joly P, Dartigues J-F, Jacqmin-Gadda H. Joint modelling of
multivariate longitudinal outcomes and a time-to-event: a nonlinear latent
class approach. Comput Stat Data Anal. 2009;53:1142–54.
46. Albert PS, Shih JH. An approach for jointly modeling multivariate longitudinal
measurements and discrete time-to-event data. Ann Appl Stat. 2010;4:1517–32.
47. Liu F, Li Q. A Bayesian model for joint analysis of multivariate repeated measures
and time to event data in crossover trials. Stat Methods Med Res. 2014;0:1–13.
48. Hu B, Li L, Greene T. Joint multiple imputation for longitudinal outcomes
and clinical events that truncate longitudinal follow-up. Stat. Med. 2015
49. Tang AM, Tang NS. Semiparametric Bayesian inference on skew–normal
joint modeling of multivariate longitudinal and survival data. Stat Med.
2015; 34: 824–843.
50. Jaffa MA, Woolson RF, Lipsitz SR. Slope estimation for bivariate longitudinal
outcomes adjusting for informative right censoring by using a discrete survival
model: application to the renal transplant cohort. J R Stat Soc Ser A Stat Soc.
2011;174:387–402.
51. Jaffa MA, Gebregziabher M, Jaffa AA. A Joint modeling approach for right
censored high dimensiondal multivariate longitudinal data. J Biometrics
Biostat. 2014; 5.
52. Guedj J, Thiébaut R, Commenges D. Joint modeling of the clinical
progression and of the biomarkers’ dynamics using a mechanistic model.
Biometrics. 2011;67:59–66.
53. Hatfield LA, Boye ME, Carlin BP. Joint modeling of multiple longitudinal
patient-reported outcomes and survival. J Biopharm Stat. 2011;21:971–91.
54. He B, Luo S. Joint modeling of multivariate longitudinal measurements and
survival data with applications to Parkinson’s disease. Stat Methods Med
Res. 2013; 0: 1–13.
55. Luo S. A Bayesian approach to joint analysis of multivariate longitudinal
data and parametric accelerated failure time. Stat Med. 2014;33:580–94.
56. Andrinopoulou E-R, Rizopoulos D, Takkenberg JJM, Lesaffre E. Combined
dynamic predictions using joint models of two longitudinal outcomes and
competing risk data. Stat Methods Med Res. 2015;0:1–18.
57. Proust-Lima C, Dartigues J-F, Jacqmin-Gadda H. Joint modelling of repeated
multivariate cognitive measures and competing risks of dementia and
death: a latent process and latent class approach. Stat. Med. 2015. In press.
58. Xu J, Zeger SL. The evaluation of multiple surrogate endpoints. Biometrics.
2001;57:81–7.
59. Andrinopoulou E-R, Rizopoulos D, Takkenberg JJM, Lesaffre E. Joint modeling of
two longitudinal outcomes and competing risk data. Stat Med. 2014;33:3167–78.
60. Tang NS, Tang AM, Pan DD. Semiparametric Bayesian joint models of multivariate
longitudinal and survival data. Comput Stat Data Anal Elsevier BV. 2014;77:113–29.
61. Bartolucci F, Farcomeni A. A discrete time event-history approach to informative
drop-out in multivariate latent Markov models with covariates. Biometrics.
2015;71:80–9.
62. Crowther MJ. Extensions to the stjm package. Leicester University; 2015.
63. Fieuws S, Verbeke G, Maes B, Vanrenterghem Y. Predicting renal graft failure
using multivariate longitudinal profiles. Biostatistics. 2008;9:419–31.
64. Baghfalaki T, Ganjali M, Berridge D. Joint modeling of multivariate longitudinal
mixed measurements and time to event data using a Bayesian approach.
J Appl Stat. 2014;41:1934–55.
65. Choi J, Anderson SJ, Richards TJ, Thompson WK. Prediction of transplant-free
survival in idiopathic pulmonary fibrosis patients using joint models for event
times and mixed multivariate longitudinal data. J Appl Stat. 2014;41:2192–205.
66. Huang W, Zeger SL, Anthony JC, Garrett E. Latent variable model for joint
analysis of multiple repeated measures and bivariate event times. J Am Stat
Assoc. 2001;96:906–14.
67. Wang C, Douglas J, Anderson S. Item response models for joint analysis of
quality of life and survival. Stat Med. 2002;21:129–42.
68. Li N, Elashoff RM, Li G, Tseng CH. Joint analysis of bivariate longitudinal
ordinal outcomes and competing risks survival times with nonparametric
distributions for random effects. Stat Med. 2012;31:1707–21.
69. Baghfalaki T, Ganjali M, Berridge D. Robust joint modeling of
longitudinal measurements and time to event data using normal/
independent distributions: a Bayesian approach. Biometrical J.
2013;55:844–65.
70. Zhu H, Ibrahim JG, Chi YY, Tang N. Bayesian influence measures for joint
models for longitudinal and survival data. Biometrics. 2012;68:954–64.
71. Song X, Davidian M, Tsiatis AA. A semiparametric likelihood approach to
joint modeling of longitudinal and time-to-event data. Biometrics.
2002;58:742–53.
72. Rizopoulos D, Verbeke G, Molenberghs G. Shared parameter models under
random-effects misspecification. Biometrika. 2008;95:63–74.
73. Brown ER, Ibrahim JG. A Bayesian semiparametric joint hierarchical model
for longitudinal and survival data. Biometrics. 2003;59:221–8.
74. Escobar MD. Estimating normal means with a Dirichiet process prior. J Am
Stat Assoc. 2012;89:268–77.
75. Royston P, Parmar MKB. Flexible parametric proportional-hazards and
proportional-odds models for censored survival data, with application to
prognostic modelling and estimation of treatment effects. Stat Med.
2002;21:2175–97.
76. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and
multi-state models. Stat Med. 2007;26:2389–430.
77. Sweeting MJ, Thompson SG. Joint modelling of longitudinal and time-to-
event data with application to predicting abdominal aortic aneurysm
growth and rupture. Biometrical J. 2011;53:750–63.
78. Faucett CL, Thomas DC. Simultaneously modelling censored survival data
and repeatedly measured covariates: a Gibbs sampling approach. Stat Med.
1996;15:1663–85.
79. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete
data via the EM algorithm. J R Stat Soc Ser B Stat Methodol. 1977;39:1–38.
80. Hsieh F, Tseng YK, Wang JL. Joint modeling of survival and longitudinal
data: Likelihood approach revisited. Biometrics. 2006;62:1037–43.
81. Lunn D, Spiegelhalter DJ, Thomas A, Best N. The BUGS project: evolution,
critique and future directions. Stat Med. 2009;28:3049–67.
82. Tsonaka R, Verbeke G, Lesaffre E. A semi-parametric shared parameter
model to handle nonmonotone nonignorable missingness. Biometrics.
2009;65:81–7.
83. Little RJA, Rubin DB. Statistical Analysis With Missing Data. Wiley Ser. Probab.
Math. Stat. New York: Wiley; 1987.
84. Fieuws S, Verbeke G. Pairwise fitting of mixed models for the joint modeling of
multivariate longitudinal profiles. Biometrics. 2006;62:424–31.
85. Plummer M. JAGS : A program for analysis of Bayesian graphical models
using Gibbs sampling. In: Hornik K, Leisch F, Zeileis A, editors. Proc. 3rd Int.
Work. Distrib. Stat. Comput. Vienna, Austria; 2003.
86. Doran HC, Lockwood JR. Fitting value-added models in R. J Educ Behav
Stat. 2006;31:205–30.
87. Crowther MJ. The stjm package in Stata: Joint modeling of longitudinal and
survival data. Jt. Stat. Meet. Seattle; 2015.
88. Wang P, Shen W, Boye ME. Joint modeling of longitudinal outcomes and
survival using latent growth modeling approach in a mesothelioma trial.
Heal Serv Outcomes Res Methodol. 2012;12:182–99.
89. Chen LM, Ibrahim JG, Chu H. Sample size and power determination in joint
modeling of longitudinal and survival data. Stat Med. 2011;30:2295–309.
Hickey et al. BMC Medical Research Methodology  (2016) 16:117 Page 15 of 15
